Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › 2,4-thiazolidinedione derivatives in the treatment of central nervous system disorders

2,4-thiazolidinedione derivatives in the treatment of central nervous system disorders

US Patent 10179126 · Granted Jan 15, 2019

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

5-[[4-[2-[5-(1-hydroxyethyl)pyridin-2-yl]ethoxy]phenyl]methyl]-1,3-thiazolidine-2024
5-[[4-[2-[5-(1-hydroxyethyl)pyridin-2-yl]ethoxy]phenyl]methyl]-1,3-thiazolidine-2024
5-[[4-[2-[5-(1-hydroxyethyl)pyridin-2-yl]ethoxy]phenyl]methyl]-1,3- thiazolidine2024
5-[[4-[2-[5-(1-hydroxyethyl)pyridin-2-yl]ethoxy]phenyl]methyl]-1,3- thiazolidine2024
Heteroaryl compounds and their use2023
Process for preparing 5-[[4-[2-[5-(1-hydroxyethyl)-2-pyridinyl]ethoxy]phenyl]-me2023
Isoquinoline compounds, methods for their preparation, and therapeutic uses ther2022
Isoquinoline compounds, methods for their preparation, and therapeutic uses ther2022
Heteroaryl compounds and their use2021
Process for preparing 5-[[4-[2-[5-(1-hydroxyethyl)-2-pyridinyl]ethoxy]phenyl]met2021
(Hetero)aryl cyclopropylamine compounds as LSD1 inhibitors2019
Arylcyclopropylamine based demethylase inhibitors of LSD1 and their medical use2019